echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > How do pharmaceutical companies deal with the five core policies? The solution is from three aspects

    How do pharmaceutical companies deal with the five core policies? The solution is from three aspects

    • Last Update: 2016-07-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: on July 4, 2016, pharmaceutical economic news, many people in the industry have been used to the mode of "heavy policy frying - a period of nothing - getting better and going back on the road" What should the pharmaceutical industry do in the environment of internal worries (economic downturn, more difficult financing) and external troubles (intensive government orders, tired of coping)? At present, the five core policies faced by the industry are: 1 Consistency evaluation It is mainly to solve the problem of low-level repeated construction It is said that the basic cost of consistency evaluation reaches 5 million yuan for a single product The production enterprises that cannot provide comparison by themselves will be eliminated, and the industry will survive the fittest by administrative means 2 "Replacing business tax with value-added tax" The original intention is "you don't collect tax or less if you don't have value-added (make money)", but before "replacing business tax with value-added tax", the industrial tax range has been increased in disguise More importantly, it reduces the items that can be reimbursed and deducted 3 The "two ticket system" will have certain effect on reducing circulation links, reducing price hikes layer by layer, and thus reducing drug prices, but it also needs relevant supporting measures Some time ago, a well run and well-known "business chain integration" enterprise in Guangdong suddenly died It's right to reduce circulation and drug price, but it just can't achieve the goal 4 Quality traceability system This is indeed a strategy that can work from theory to operation, but from the production enterprise to the consumer, to achieve one-to-one traceability, there is no doubt that it will increase the operating cost, and where will this cost be apportioned? Worthy of attention 5 Hospital zero price difference 70% or more of the sales are completed in hospitals, and the best medical resources are almost in the second tier hospitals and above The state is determined to solve all kinds of corruption and problems caused by "medicine for medical treatment", but for hospital practitioners, there is neither value education nor strong system supervision, just a "zero difference price" To cut off the interest contact between product providers and hospital decision makers As a result, the consistent relationship between doctors and patients has become a confrontation and game In addition, there are various government orders in various sub industries, such as hierarchical diagnosis and treatment, "Three Guarantees in one", centralized collection with different faces, charging by disease, telemedicine, e-commerce, etc "One normal" means that flight inspection becomes normal The combination of intensive policies and orders will cause unpredictable shocks to the industry When the main enterprises in the industry are unable to control the trend in a panoramic way, there will inevitably be various rumors and emotions What should we do? So, the assassin's mace appears The flight inspection is aimed at the whole industry, either for rectification, or for revoking the business license and banning the certificate It is said that the flight inspection of drugstores began in July Reshaping the operation mode is not a matter of our generation at the national and policy level In such an environment, what should pharmaceutical companies do? The author adheres to the principles of systematization, comprehensiveness and effectiveness, and gives solutions from three aspects: first, upgrade the enterprise strategy and reshape the operation mode If speculators or cross-border enterprises look for a way back and firmly choose pharmaceutical enterprises, they should set up enterprise strategy and operation mode There are two main points in upgrading the enterprise strategy: first, to lengthen the time for the realization of the strategy The strategy originally planned to be realized in three years may take four to five years to realize, so as to strive for space for the realization of the strategy, so-called "time for space" Second, based on the actual situation and the predictable future, the business model, management model and profit model are reorganized In accordance with the government order, we can't "wait to rely on it" and solve it as soon as possible to ensure competitive advantage Second, build an efficient team and strengthen cost management A group of people is needed from pharmaceutical companies to pharmaceutical companies, and a group of people is needed from commercial companies to terminals The business team focuses on the interaction and control with the business, and the distribution team focuses on terminal aided development, based on which the sales organization is set At the same time, pay attention to the cost As Liu qiangdong said, "the key is not how much you earn, but how low your cost is." Strengthening cost management is not only for making more money, but also for the normal operation of enterprises in the future It is a kind of competitive advantage The savings from purchase cost, management cost, financial cost, sales cost to human resource cost are not realized by "deduction", but based on benefit use cost Third, focus on big items and improve market efficiency Our market is large enough, but many provinces and cities have not carried out long-term development step by step After a year, we haven't realized the maximization of market efficiency In fact, when you can't eat a fat man, you can divide it into three, five, and ten years, digest it slowly and introduce it gradually The large single products here are not necessarily the products with the highest profits of the enterprise, but the products with the most characteristics or the products with the most advantages According to the rules of the game required by the decree, the limited enterprise resources are concentrated, released accurately and gradually until the product and market expectations are realized According to the planning of market classification, market target and market rhythm, when it is gradually combined with products, or even unable to "cross the country with one product", we can save the country with a curve "one area, one product", put the appropriate varieties in the appropriate market, and then gradually look for opportunities to become bigger and stronger When the plan or commitment one year ago or five years ago is to be fulfilled, in case of sudden change of policy environment, it is not necessary to carry it out for the sake of face, nor to make efforts blindly for the realization of the plan There is no choice but to abide by the policy, comply with the reform and operate in accordance with the law!
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.